4//SEC Filing
Liu Suying 4
Accession 0000899243-21-042255
CIK 0001832415other
Filed
Oct 31, 8:00 PM ET
Accepted
Nov 1, 8:59 PM ET
Size
17.5 KB
Accession
0000899243-21-042255
Insider Transaction Report
Form 4
Liu Suying
DirectorChief Executive Officer10% Owner
Transactions
- Other
Rights
2021-10-28+142,500→ 0 total(indirect: See Footnote)Exercise: $0.00→ Common Stock (14,250 underlying) - Award
Stock Option (Right to Buy)
2021-10-28+28,300→ 28,300 totalExercise: $10.97Exp: 2031-10-27→ Common Stock (28,300 underlying) - Other
Common Stock
2021-10-28+1,388,250→ 0 total(indirect: See Footnote) - Other
Common Stock
2021-10-28+14,250→ 1,388,250 total(indirect: See Footnote)
Footnotes (6)
- [F1]Acquired 14,250 shares of common stock through the automatic conversion of rights whereby 142,500 rights automatically converted into 14,250 shares of common stock upon consummation of the business combination between Mountain Crest Acquisition Corp II ("Mountain Crest II") and Better Therapeutics Inc. ("Business Combination").
- [F2]No consideration was paid as these shares were acquired as a result of the automatic conversion of rights upon consummation of the Business Combination.
- [F3]Shares of common stock held by Mountain Crest Capital LLC of which Dr. Suying Liu and Mr. Dong Liu were the Managing Members prior to October 28, 2021. On October 28, 2021, Dr. Suying Liu resigned from his position as a managing member of Mountain Crest Capital LLC.
- [F4]On October 28, 2021, Dr. Suying Liu resigned from his position as a managing member of Mountain Crest Capital LLC and no longer beneficially owns the shares held by it.
- [F5]Disposition of 142,500 rights through the automatic conversion of such rights into 14,250 shares of common stock upon consummation of the Business Combination.
- [F6]Following the Issuer's filing of Form S-8 to register the shares subject to the stock option, the stock option vests as to 1/3 of the shares subject to the stock option on October 28, 2022 and the remaining shares vest in 24 equal monthly installments thereafter, provided the Reporting Person continues to have a service relationship with Issuer on each vesting date. The stock option was granted on October 28, 2021.
Issuer
Better Therapeutics, Inc.
CIK 0001832415
Entity typeother
Related Parties
1- filerCIK 0001811534
Filing Metadata
- Form type
- 4
- Filed
- Oct 31, 8:00 PM ET
- Accepted
- Nov 1, 8:59 PM ET
- Size
- 17.5 KB